Kirby Institute Seminar Series presents
National Institute for Health and Care Excellence (NICE) recommends the promotion of HCV case-finding in “higher risk” people in primary care and specialist drug clinics. But there was no robust RCT evidence of specific interventions. We report on two studies:
- HepCATT (Hepatitis C Assessment to Treatment Trial) in Primary Care: a cluster RCT of whether a complex intervention based on a risk prediction algorithm tool is effective, acceptable and cost-effective, and can increase testing and diagnosis of HCV in primary care;
- HepCATT in community drug clinics: a non-randomised controlled study of the effectiveness and cost effectiveness of HCV facilitators aiming to improve uptake of HCV testing and linkage to care.
Both studies were found to be effective and cost-effective.